| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c45f3f15395ecd80506aa6c37fe3cb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5972bec91115958634b84fd69fa5816c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f708f49e9e89eb2d377058d7326c1f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate |
2013-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449d52b0931ada428ea36cff2f35b449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e9c8204c070e0b541ac356852b5f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eefdf700853890f7a29fc004a0da599a |
| publicationDate |
2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104582711-A |
| titleOfInvention |
Induced pluripotent stem cells for repair and regeneration of myocardial infarction |
| abstract |
The present invention aims to provide a new medical application using pluripotent stem cells (Muse cells) in regenerative medicine. The present invention provides a cell preparation containing SSEA-3-positive pluripotent stem cells isolated from interstitial tissue or cultured interstitial cells of a living body and used for treating myocardial infarction, especially severe large myocardial infarction, and heart failure associated therewith . The cell preparation of the present invention is based on the regeneration mechanism of myocardial tissue in which Muse cells are selectively accumulated in myocardial tissue by intravenous administration of Muse cells to subjects with the above-mentioned diseases and differentiated into the myocardium in the tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109843308-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109689074-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016168993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106822899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109689073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109789168-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111225676-A |
| priorityDate |
2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |